Navigation Links
LS9, Inc., the Renewable Petroleum Company(TM), Adds Key Positions to Executive Team and Scientific Advisory Board
Date:2/6/2008

Wei Huang named Vice President of Process Development and Engineering

Christopher Stone named Vice President of Legal Affairs

Drs. John Cronan and Uwe Sauer Join Scientific Advisory Board

SAN CARLOS, Calif., Feb. 6 /PRNewswire/ -- LS9, Inc., the Renewable Petroleum Company(TM), today announced the addition of two key members of its executive team: Wei Huang has been named the company's Vice President of Process Development and Engineering, and Christopher Stone has been named the company's Vice President of Legal Affairs.

Wei Huang, who was previously Director of Process Engineering at Fluor Corporation, one of the world's largest, publicly-owned engineering companies, will oversee the company's process engineering and scale-up of DesignerBiofuels(TM) products. Ms. Huang brings more than 17 years of experience in process development, scale up and product commercialization for the biotechnology and chemical industries. Her expertise in facility and equipment design and operations support will be critical in the company's production and commercialization of advanced biofuels.

Also, to ensure the company's strong leadership in intellectual property, patents, and strategic partnerships, Christopher Stone has joined the LS9 management team to oversee the company's legal affairs. Mr. Stone brings 17 years of legal, intellectual property, and transaction experience, including 12 years working in the industrial biotechnology sector. Prior to joining LS9, Mr. Stone held the roles of Vice President, Intellectual Assets at Danisco A/S and Vice President, General Patent Counsel at Genencor International, Inc. Mr. Stone's responsibilities at the company will include intellectual property protection and management, contract negotiation and drafting, participation in business operations and strategic planning, and litigation management.

"We are truly fortunate to be joined by both Wei Huang and Chris Stone as we've moved into commercialization," said Robert Walsh, President of LS9. "Both combine exceptional talent with years of experience bringing new products to market, and will extend our leadership position for hydrocarbon biofuels," he said.

In addition, LS9 has expanded its scientific advisory board to further development of Renewable Petroleum(TM) technology with the addition of distinguished scientists Dr. John Cronan and Dr. Uwe Sauer. Dr. Cronan is Alumni Professor of Microbiology and Professor of Biochemistry at the University of Illinois, Urbana-Champaign, and also serves as Head of the Department of Microbiology. He pioneered genetic approaches to understanding the mechanisms and regulation of bacterial lipid metabolism and is a leading expert on fatty acid biosynthesis. Dr. Uwe Sauer is Professor of Systems Biology in the Department of Biology at the Swiss Federal Institute of Technology in Zurich. He is a well-recognized expert on central metabolism of bacteria and yeast.

About LS9

LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held biotechnology company and the pioneer in the commercial development of hydrocarbon biofuels. LS9 is pursuing industrial applications of synthetic biology to produce proprietary hydrocarbon biofuels that are compatible with existing fuel distribution and consumer infrastructure. LS9's patent-pending DesignerBiofuels(TM) products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. The venture capital firms Flagship Ventures, Khosla Ventures and Lightspeed Venture Partners have provided funding to date. LS9 is headquartered in San Carlos, California, in the heart of Silicon Valley. http://www.ls9.com.


'/>"/>
SOURCE LS9, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
2. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
5. BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
6. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
7. ADVENTRX Announces Consolidation of Clinical and Management Positions
8. Monsanto Executives to Address Investor Conferences in February
9. BioSeek Elects Roy Whitfield Executive Chairman of Board of Directors
10. China Pharma Appoints Three Independent Non-Executive Directors
11. Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... FRANCISCO , June 22, 2016  Amgen (NASDAQ: ... sponsorship of the QB3@953 life sciences incubator ... human health. The shared laboratory space at QB3@953 was ... overcome a key obstacle for many early stage organizations ... part of the sponsorship, Amgen launched two "Amgen Golden ...
Breaking Biology Technology:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):